ASXL1 and acute myeloid leukemia: BRD4 inhibition reduced the expression of self-renewal genes in ASXL1mut AML by inhibiting the interaction between mutated ASXL1 and BRD4, suggesting BET inhibitors may have a role in ASXL1mut AML [65].